These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1939396)
1. Fast drug-receptor mapping by site-directed distances: a novel method of predicting new pharmacological leads. Smellie AS; Crippen GM; Richards WG J Chem Inf Comput Sci; 1991 Aug; 31(3):386-92. PubMed ID: 1939396 [TBL] [Abstract][Full Text] [Related]
2. A new approach to the automatic identification of candidates for ligand receptor sites in proteins: (I). Search for pocket regions. Del Carpio CA; Takahashi Y; Sasaki S J Mol Graph; 1993 Mar; 11(1):23-9, 42. PubMed ID: 8499393 [TBL] [Abstract][Full Text] [Related]
3. Flexibases: a way to enhance the use of molecular docking methods. Kearsley SK; Underwood DJ; Sheridan RP; Miller MD J Comput Aided Mol Des; 1994 Oct; 8(5):565-82. PubMed ID: 7876901 [TBL] [Abstract][Full Text] [Related]
5. A multiple-start Monte Carlo docking method. Hart TN; Read RJ Proteins; 1992 Jul; 13(3):206-22. PubMed ID: 1603810 [TBL] [Abstract][Full Text] [Related]
6. Docking molecules by families to increase the diversity of hits in database screens: computational strategy and experimental evaluation. Su AI; Lorber DM; Weston GS; Baase WA; Matthews BW; Shoichet BK Proteins; 2001 Feb; 42(2):279-93. PubMed ID: 11119652 [TBL] [Abstract][Full Text] [Related]
7. The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling. Hong W; Wang Y; Chang Z; Yang Y; Pu J; Sun T; Kaur S; Sacchettini JC; Jung H; Lin Wong W; Fah Yap L; Fong Ngeow Y; Paterson IC; Wang H Sci Rep; 2015 Oct; 5():15328. PubMed ID: 26471125 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors. Zhou X; Lin K; Ma X; Chui WK; Zhou W Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545 [TBL] [Abstract][Full Text] [Related]
9. A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region. Summerfield RL; Daigle DM; Mayer S; Mallik D; Hughes DW; Jackson SG; Sulek M; Organ MG; Brown ED; Junop MS J Med Chem; 2006 Nov; 49(24):6977-86. PubMed ID: 17125251 [TBL] [Abstract][Full Text] [Related]
10. Contributions of tryptophan 24 and glutamate 30 to binding long-lived water molecules in the ternary complex of human dihydrofolate reductase with methotrexate and NADPH studied by site-directed mutagenesis and nuclear magnetic resonance spectroscopy. Meiering EM; Li H; Delcamp TJ; Freisheim JH; Wagner G J Mol Biol; 1995 Mar; 247(2):309-25. PubMed ID: 7707377 [TBL] [Abstract][Full Text] [Related]
11. Defining the binding site of homotetrameric R67 dihydrofolate reductase and correlating binding enthalpy with catalysis. Strader MB; Chopra S; Jackson M; Smiley RD; Stinnett L; Wu J; Howell EE Biochemistry; 2004 Jun; 43(23):7403-12. PubMed ID: 15182183 [TBL] [Abstract][Full Text] [Related]
12. A glutamine 67--> histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition. Park H; Bradrick TD; Howell EE Protein Eng; 1997 Dec; 10(12):1415-24. PubMed ID: 9543003 [TBL] [Abstract][Full Text] [Related]
13. Structural Characterization of Dihydrofolate Reductase Complexes by Top-Down Ultraviolet Photodissociation Mass Spectrometry. Cammarata MB; Thyer R; Rosenberg J; Ellington A; Brodbelt JS J Am Chem Soc; 2015 Jul; 137(28):9128-35. PubMed ID: 26125523 [TBL] [Abstract][Full Text] [Related]
14. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase. Srinivasan B; Tonddast-Navaei S; Skolnick J Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808 [TBL] [Abstract][Full Text] [Related]
15. Breaking symmetry: mutations engineered into R67 dihydrofolate reductase, a D2 symmetric homotetramer possessing a single active site pore. Smiley RD; Stinnett LG; Saxton AM; Howell EE Biochemistry; 2002 Dec; 41(52):15664-75. PubMed ID: 12501195 [TBL] [Abstract][Full Text] [Related]
16. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity. Ng HL; Chen S; Chew EH; Chui WK Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844 [TBL] [Abstract][Full Text] [Related]
17. Ab initio studies of 2,4-diamino triazine and its complexes with ligands: a model for inhibitor-active site interactions of dihydrofolate reductase. Sapse AM; Waltham MC; Bertino JR Cancer Invest; 1994; 12(5):469-76. PubMed ID: 7922702 [TBL] [Abstract][Full Text] [Related]
18. Role of S65, Q67, I68, and Y69 residues in homotetrameric R67 dihydrofolate reductase. Strader MB; Smiley RD; Stinnett LG; VerBerkmoes NC; Howell EE Biochemistry; 2001 Sep; 40(38):11344-52. PubMed ID: 11560482 [TBL] [Abstract][Full Text] [Related]
19. High-resolution structure of a plasmid-encoded dihydrofolate reductase: pentagonal network of water molecules in the D2-symmetric active site. Narayana N Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):695-706. PubMed ID: 16790925 [TBL] [Abstract][Full Text] [Related]